Back to Search Start Over

Isolation of a novel isoprenylated phenolic compound and neuroprotective evaluation of Dodonaea viscosa extract against cerebral ischaemia-reperfusion injury in rats.

Authors :
Almarfadi OM
Siddiqui NA
Shahat AA
Fantoukh OI
El Gamal AA
Raish M
Bari A
Iqbal M
Alqahtani AS
Source :
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society [Saudi Pharm J] 2024 Jan; Vol. 32 (1), pp. 101898. Date of Electronic Publication: 2023 Dec 09.
Publication Year :
2024

Abstract

Dodonaea viscosa grows widely in Saudi Arabia, but studies evaluating its neuroprotective activity are lacking. Thus, this study aimed to isolate and identify the secondary metabolites and evaluate the neuroprotective effects of D. viscosa leaves. The isolation and identification of phytochemicals were performed using chromatographic and spectroscopic techniques. The neuroprotective potential of the extract was evaluated against focal cerebral ischaemia-reperfusion injury in rat model. Neurobehavioural deficits in the rats were evaluated, and their brains were harvested to measure infarct volume and oxidative biomarkers. Results revealed the presence of three compounds: a novel isoprenylated phenolic derivative that was elucidated as 4-hydroxy-3-(3'-methyl-2'-butenyl) phenyl 1-O-β-D-apiosyl-(1''' → 6'')- β-D-glucopyranoside (named Viscomarfadol) and two known compounds (isorhamnetin-3-O-rutinoside and epicatechin (4-8) catechin). Pre-treatment of the rats with the extract improved neurological outcomes. It significantly reduced neurological deficits and infarct volume; significantly reduced lipid peroxidation, as evidenced by decreased malondialdehyde levels; and significantly elevated antioxidant (superoxide dismutase, catalase, and glutathione) activities. These results indicate that D. viscosa is a promising source of bioactive compounds that can improve neurological status, decrease infarct volume, and enhance antioxidant activities in rats with cerebral ischaemic injury. Thus, D. viscosa could be developed into an adjuvant therapy for ischaemic stroke and other oxidative stress-related neurodegenerative disorders. Further investigations are warranted to explore other bioactive compounds in D. viscosa and evaluate their potential neuroprotective activities.<br />Competing Interests: The authors declare that they have no competing financial interests or personal relationships that may have influenced the work reported in this study.<br /> (© 2023 The Authors. Published by Elsevier B.V. on behalf of King Saud University.)

Details

Language :
English
ISSN :
1319-0164
Volume :
32
Issue :
1
Database :
MEDLINE
Journal :
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Publication Type :
Academic Journal
Accession number :
38192384
Full Text :
https://doi.org/10.1016/j.jsps.2023.101898